Greenyn Biotechnology Co (ROCO:6846) Days Sales Outstanding : 42.64 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Days Sales Outstanding?

Greenyn Biotechnology Co's average Accounts Receivable for the three months ended in Mar. 2024 was NT$105.7 Mil. Greenyn Biotechnology Co's Revenue for the three months ended in Mar. 2024 was NT$226.2 Mil. Hence, Greenyn Biotechnology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 42.64.

The historical rank and industry rank for Greenyn Biotechnology Co's Days Sales Outstanding or its related term are showing as below:

ROCO:6846' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.05 Med: 41.7 Max: 49.84
Current: 42.83

During the past 5 years, Greenyn Biotechnology Co's highest Days Sales Outstanding was 49.84. The lowest was 36.05. And the median was 41.70.

ROCO:6846's Days Sales Outstanding is ranked better than
75.45% of 888 companies
in the Biotechnology industry
Industry Median: 72.545 vs ROCO:6846: 42.83

Greenyn Biotechnology Co's Days Sales Outstanding increased from Mar. 2023 (41.72) to Mar. 2024 (42.64).

Greenyn Biotechnology Co Days Sales Outstanding Historical Data

The historical data trend for Greenyn Biotechnology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Days Sales Outstanding Chart

Greenyn Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

49.84

37.79

36.05

42.28

41.70

Greenyn Biotechnology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial										41.72	41.72	45.06	40.95	42.64

Competitive Comparison of Greenyn Biotechnology Co's Days Sales Outstanding

For the Biotechnology subindustry, Greenyn Biotechnology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenyn Biotechnology Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Greenyn Biotechnology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Greenyn Biotechnology Co's Days Sales Outstanding falls into.

Greenyn Biotechnology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Greenyn Biotechnology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (83.788	+	99.102)	/	2 )	/	800.511	*	365
=	91.445					/	800.511	*	365
=	41.70

Greenyn Biotechnology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (99.102	+	112.271)	/	2 )	/	226.161	*	365 / 4
=	105.6865					/	226.161	*	365 / 4
=	42.64

Greenyn Biotechnology Co (ROCO:6846) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Greenyn Biotechnology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenyn Biotechnology Co (ROCO:6846) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No 43 Keya Road, Daya District, Taichung, TWN

Website

https://www.greenynbio.com

Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines